Synthetic Developments for the Treatment of Organophosphorus Nerve Agent Poisoning

Total Page:16

File Type:pdf, Size:1020Kb

Synthetic Developments for the Treatment of Organophosphorus Nerve Agent Poisoning Synthetic Developments for the Treatment of Organophosphorus Nerve Agent Poisoning DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Amneh Young Graduate Program in Chemistry The Ohio State University 2016 Dissertation Committee: Professor Christopher M. Hadad, Advisor Professor Jon R. Parquette Professor Thomas M. Magliery Copyrighted by Amneh Young 2016 Abstract Acetylcholinesterase (AChE) is a serine hydrolase responsible for the hydrolysis of the neurotransmitter acetylcholine. It hydrolyzes over 25,000 acetylcholine (ACh) molecules every second. Inhibition of AChE catalytic site results in muscle contractions, blurry vision, seizures, and respiratory failure. Organophosphorus (OP) compounds are potent inhibitors of the enzyme AChE. Once the OP enters the enzyme active site, it phosphylates a serine residue (Ser203) to give an irreversibly inhibited AChE that is incapable of hydrolyzing ACh. This leads to a buildup of ACh at cholinergic receptors and constant stimulation of nerve fibers. Reactivation of AChE can occur by hydrolysis of the phosphylated enzyme which is usually accomplished by use of a nucleophilic oxime, such as 2-PAM, often administered after OP exposure as a treatment. However, if reactivation does not occur, the phosphylated enzyme will then undergo a spontaneous dealkylation process (called aging) to give an aged enzyme which, to date, cannot be reactivated. This dissertation covers multiple strategies to combat OP poisoning. First is the design of a pre-treatment in the form of catalytic antibodies capable of hydrolyzing OPs before they can inhibit AChE. The potential for antibodies to catalyze hydrolysis reactions inspired several reports of abzyme neutralization of OP nerve agents. To produce the catalytic antibodies, our group designed and synthesized a small library of haptens that mimic the transition state of nerve agent hydrolysis. These haptens are then ii conjugated to an immunogenic protein and antibodies are raised that hopefully hydrolyze nerve agents before they can inhibit AChE. Ten haptens were synthesized and preliminary results indicate that these haptens either bind or hydrolyze our target OP nerve agent. The second approach is the use of a cyclic peptide to mimic the active site of known OP bioscavengers. A combinatorial approach was used to develop a library of peptides synthesized on a bead using common solid phase peptide chemistry. A novel screening approach will be discussed. The final strategy is the design of quinone methide precursors (QMPs) that will enter the active site of AChE and alkylate the “aged” enzyme. Once alkylated, AChE can be reactivated using a nucleophilic oxime (2-PAM). Our goal is to design QMPs which will bind to and selectively alkylate aged AChE. We designed four different families of QMPs that can be easily accessed via simple transformations of commercially available starting materials. An undergraduate organic chemistry lab experiment was designed to aid in the synthesis of the QMP library and produced over 100 QMPs in gram quantities. Approximately half of the QMPs react with model nucleophiles under physiological conditions. The reactivity of these QMPs with model phosphonylated peptides and aged AChE will be discussed. iii Dedication To my loving husband Philip iv Acknowledgments There are many people who have helped me grow and succeed, both on an academic and personal level. I must first thank the people who mentored me through my graduate career: Professor Chris Hadad for helping me achieve my goals and for the freedom to pursue my own projects, and Dr. James Stambuli for teaching me the skills I needed to succeed and giving me continued guidance to help me find my path. Dr. Will Henderson showed me the ropes when I first started graduate school and Dr. Matt Lauer continued my training-teaching me everything I know about Wittig reactions and softball. All the Stambuli group members made work truly enjoyable and intellectually stimulating. I would like to thank Tom Corrigan, Chi Le, Ben Garrett, Ryan McKenney, Dr. Jeremey Erb, Qinggeng Zhuang, and our many collaborators for making the Hapten project a success. Special thanks to Ryan McKenney for helping me turn my idea of cyclic peptides as OP scavengers into a reality. Professor Dehua Pei was instrumental in the design of that project and without his guidance our success would have been unlikely. There are so many people involved in the QMP project, many of which I haven’t worked with directly, but without whom the project would likely still be in infancy. There are countless undergraduate students, under the guidance of Dr. Chris Callam, who did the bulk of the synthesis. Qinggeng Zhuang, worked tirelessly on this project to identify hit compounds. v My graduate career followed an unconventional path and I would like to thank the people who helped me navigate those waters-I would not be where I am today without them. Ben Garrett and Luke Baldwin patiently counseled me over many months while I struggled to determine my best course of action. I am really glad I listened to both of you. Professor Chris Hadad and Dr. James Stambuli always had an open door and listened to me before doing everything in their capacity to help me accomplish my goals. I am lucky to have both of you on my side. Finally, I would like to thank my wonderful husband Philip for all the love, support, and happiness you bring to my life. I look forward to the years ahead and all the adventures we will have along the way. vi Vita 2011................................................................B.S. Chemistry and Biochemistry, The University of Michigan-Dearborn 2014................................................................M.S. Chemistry, The Ohio State University 2011 to present ..............................................Graduate Research Associate, Department of Chemistry and Biochemistry, The Ohio State University Publications 1. Palladium-Catalyzed Reactions of Enol Ethers: Access to Enals, Furans, and Dihydrofurans. Lauer, M.G.; Henderson, W.H.; Awad, A.; Stambuli, J.P. Org. Lett. 2012, 14, 6000 – 6003. 2. Dimeric FeFe-Hydrogenase Mimics Bearing Carboxylic Acids: Synthesis and Electrochemical Investigation. Garrett, B.R.; Awad, A.; He, M.; Click, K.; Durr, C.; Gallucci, J.; Hadad, C.M.; Wu, Y. Polyhedron 2016, 103, 21-27. vii Fields of Study Major Field: Chemistry viii Table of Contents Abstract ............................................................................................................................... ii Acknowledgments............................................................................................................... v Vita .................................................................................................................................... vii List of Schemes ................................................................................................................. xii List of Tables .................................................................................................................... xv List of Figures .................................................................................................................. xvi List of Abbreviations ....................................................................................................... xix CHAPTER 1: INTRODUCTION TO ORGANOPHOSPHORUS NERVE AGENTS AND AChE ......................................................................................................................... 1 1.1: Brief History of the Development and Use of Organophosphorus Nerve Agents ... 1 1.2: Use of OP Compounds as Pesticides ....................................................................... 4 1.3: Structure and Activity of Acetylcholinesterase........................................................ 6 1.4: Current Therapies for OP Inhibition of AChE ....................................................... 10 1.5: Statement of Purpose.............................................................................................. 15 CHAPTER 2: SYNTHESIS OF NOVEL PHOSPHORANE HAPTENS ........................ 16 ix 2.1: Introduction ............................................................................................................ 16 2.2: Division of Work Described in this Chapter .......................................................... 23 2.3: Hapten Design and Synthesis ................................................................................. 24 2.4: Results and Discussion ........................................................................................... 45 2.5: Conclusions ............................................................................................................ 54 CHAPTER 3: DEVELOPMENT OF CYCLIC PEPTIDES FOR VX HYDROLYSIS ... 56 3.1: Introduction ............................................................................................................ 56 3.2: Division of Work Described in this Chapter .......................................................... 62 3.3: Cyclic Peptide Design and Synthesis ..................................................................... 62 3.4: Model Phosphonate Design and Synthesis ............................................................ 67 3.5: Screening Protocols and Hit Identification ............................................................ 74 3.6: Future Directions ...................................................................................................
Recommended publications
  • Alcohols Combined 1405
    ALCOHOLS COMBINED 1405 Formulas: Table 1 MW: Table 1 CAS: Table 2 RTECS: Table 2 METHOD: 1405, Issue 1 EVALUATION: PARTIAL Issue 1: 15 March 2003 OSHA : Table 2 PROPERTIES: Table 1 NIOSH: Table 2 ACGIH: Table 2 COMPOUNDS: (1) n-butyl alcohol (4) n-propyl alcohol (7) cyclohexanol (2) sec-butyl alcohol (5) allyl alcohol (8) isoamyl alcohol (3) isobutyl alcohol (6) diacetone alcohol (9) methyl isobutyl carbinol SYNONYMS: See Table 3. SAMPLING MEASUREMENT SAMPLER: SOLID SORBENT TUBE TECHNIQUE: GAS CHROMATOGRAPHY, FID (Coconut shell charcoal, 100 mg/50 mg) ANALYTE: Compounds above FLOW RATE: 0.01 to 0.2 L/min DESORPTION: 1 mL 5% 2-propanol in CS2 Compounds: (1-3 ) (4-9) VOL-MIN: 2 L 1 L INJECTION -MAX: 10 L 10 L VOLUME: 1 µL SHIPMENT: Routine TEMPERATURE -INJECTION: 220 °C SAMPLE -DETECTOR: 250 - 300 °C STABILITY: See Evaluation of Method. -COLUMN: 35 °C (7 minutes), to 60 °C at 5 °C/minute, hold 5 minutes, up to BLANKS: 2 to 10 field blanks per set 120 °C at 10 °C /minute, hold 3 minutes. CARRIER GAS: He, 4 mL/min ACCURACY COLUMN: Capillary, fused silica, 30 m x 0.32-mm RANGE STUDIED: Not studied [1, 2]. ID; 0.5 µm film polyethylene glycol, DB- wax or equivalent BIAS: Not determined CALIBRATION: Solutions of analyte in eluent (internal OVERALL standard optional) PRECISION (Ö ): Not determined rT RANGE: See EVALUATION OF METHOD. ACCURACY: Not determined ESTIMATED LOD: 1 µg each analyte per sample PRECISION: See EVALUATION OF METHOD. APPLICABILITY: This method may be used to determine two or more of the specified analytes simultaneously.
    [Show full text]
  • Aldrich FT-IR Collection Edition I Library
    Aldrich FT-IR Collection Edition I Library Library Listing – 10,505 spectra This library is the original FT-IR spectral collection from Aldrich. It includes a wide variety of pure chemical compounds found in the Aldrich Handbook of Fine Chemicals. The Aldrich Collection of FT-IR Spectra Edition I library contains spectra of 10,505 pure compounds and is a subset of the Aldrich Collection of FT-IR Spectra Edition II library. All spectra were acquired by Sigma-Aldrich Co. and were processed by Thermo Fisher Scientific. Eight smaller Aldrich Material Specific Sub-Libraries are also available. Aldrich FT-IR Collection Edition I Index Compound Name Index Compound Name 3515 ((1R)-(ENDO,ANTI))-(+)-3- 928 (+)-LIMONENE OXIDE, 97%, BROMOCAMPHOR-8- SULFONIC MIXTURE OF CIS AND TRANS ACID, AMMONIUM SALT 209 (+)-LONGIFOLENE, 98+% 1708 ((1R)-ENDO)-(+)-3- 2283 (+)-MURAMIC ACID HYDRATE, BROMOCAMPHOR, 98% 98% 3516 ((1S)-(ENDO,ANTI))-(-)-3- 2966 (+)-N,N'- BROMOCAMPHOR-8- SULFONIC DIALLYLTARTARDIAMIDE, 99+% ACID, AMMONIUM SALT 2976 (+)-N-ACETYLMURAMIC ACID, 644 ((1S)-ENDO)-(-)-BORNEOL, 99% 97% 9587 (+)-11ALPHA-HYDROXY-17ALPHA- 965 (+)-NOE-LACTOL DIMER, 99+% METHYLTESTOSTERONE 5127 (+)-P-BROMOTETRAMISOLE 9590 (+)-11ALPHA- OXALATE, 99% HYDROXYPROGESTERONE, 95% 661 (+)-P-MENTH-1-EN-9-OL, 97%, 9588 (+)-17-METHYLTESTOSTERONE, MIXTURE OF ISOMERS 99% 730 (+)-PERSEITOL 8681 (+)-2'-DEOXYURIDINE, 99+% 7913 (+)-PILOCARPINE 7591 (+)-2,3-O-ISOPROPYLIDENE-2,3- HYDROCHLORIDE, 99% DIHYDROXY- 1,4- 5844 (+)-RUTIN HYDRATE, 95% BIS(DIPHENYLPHOSPHINO)BUT 9571 (+)-STIGMASTANOL
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0156618 A1 Tollefson (43) Pub
    US 20090156618A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0156618 A1 Tollefson (43) Pub. Date: Jun. 18, 2009 (54) 1-(1-(2-ETHOXYETHYL)-3-ETHYL-7- Related U.S. Application Data (4-METHYLPYRIDIN-2-YLAMINO) - 1H-PYRAZOLO 4.3-D PYRIMIDIN-5-YL) (60) Provisional application No. 60/735,320, filed on Nov. PPERDINE-4-CARBOXYLIC ACID AND 10, 2005. SALTS THEREOF Publication Classification (51) Int. Cl. (75) Inventor: Michael B. Tollefson, Dardenne A 6LX 3/59 (2006.01) Prairie, MO (US) C07D 487/04 (2006.01) A6IP 9/12 (2006.01) A6IP 25/00 (2006.01) Correspondence Address: A6IP 9/00 (2006.01) PFZER INC. PATENT DEPARTMENT, Bld 114 M/S 114, (52) U.S. Cl. ...................................... 514/262.1; 54.4/262 EASTERN PONT ROAD (57) ABSTRACT GROTON, CT 06340 (US) The present invention comprises 1-(1-(2-ethoxyethyl)-3- ethyl-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo 4.3-d (73) Assignee: Pfizer Inc pyrimidin-5-yl)piperidine-4-carboxylic acid and its salts. The invention further comprises pharmaceutical composi tions, methods of treatment, and synthetic methods relating to (21) Appl. No.: 111558,306 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2- ylamino)-1H-pyrazolo 4.3-dipyrimidin-5-yl)piperidine-4- (22) Filed: Nov. 9, 2006 carboxylic acid and its salts. Patent Application Publication Jun. 18, 2009 Sheet 2 of 2 US 2009/0156618 A1 "SOIHZ US 2009/0156618 A1 Jun. 18, 2009 1-(1-(2-ETHOXYETHYL)-3-ETHYL-7- 1H-pyrazolo 4,3-dipyrimidin-5-yl)piperidine-4-carboxylic (4-METHYLPYRIDIN-2-YLAMINO) - acid and its pharmaceutically acceptable salts.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,455,647 B2 Delong Et Al
    USOO8455647B2 (12) United States Patent (10) Patent No.: US 8,455,647 B2 deLong et al. (45) Date of Patent: *Jun. 4, 2013 (54) 6-AMINOISOQUINOLINE COMPOUNDS 7,671,205 B2 3/2010 deLong et al. 8,034,943 B2 10/2011 delong et al. 2004/0091946 A1 5/2004 Oakley et al. (75) Inventors: Mitchell A. deLong, Chapel Hill, NC 2005/OO32125 A1 2/2005 Oakley et al. (US); Jill Marie Sturdivant, Chapel 2005/0176712 A1 8/2005 Wakabayashi et al. Hill, NC (US); Geoffrey Richard 2005/0282805 A1 12/2005 Hangeland et al. Heintzelman, Durham, NC (US); Susan 2006/027O670 A1 11/2006 Chew et al. M. Royalty, Cary, NC (US) 2007/011 1983 A1 5/2007 Fong 2007/O123561 A1 5/2007 Lee et al. 2007/01294.04 A1 6/2007 Hagihara et al. (73) Assignee: Aerie Pharmaceuticals, Inc., Research 2007/O135499 A1 6/2007 deLong et al. Triangle Park, NC (US) 2007/0142429 A1 6/2007 deLong et al. 2007/O149473 A1 6/2007 Chatterton et al. (*) Notice: Subject to any disclaimer, the term of this 2007/014.9548 A1 6/2007 Hellberg et al. patent is extended or adjusted under 35 2007/0167444 A1 7/2007 Kuramochi et al. 2007/0173530 A1 7/2007 deLong et al. U.S.C. 154(b) by 0 days. 2007/0238741 A1 10/2007 Nagarathnam et al. 2008, 0021026 A1 1/2008 Kahraman et al. This patent is Subject to a terminal dis 2008, 0021217 A1 1/2008 Borchardt et al. claimer. 2008, OO58384 A1 3/2008 Lee et al.
    [Show full text]
  • October 1, 2020 Webinar
    Phosphorus Specialties: the cornerstone of synthesis for pharmaceutical applications Eamonn Conrad, Ph.D., Global BD Manager Dino Amoroso, Ph.D., NA Account Manager William Stibbs, Ph.D. Senior BD Manager Overview • Solvay Phosphorus Specialties, Strem Chemicals Inc. Partnership • Chemistry for the Manufacture of Phosphine Ligands • Applications in Pharmaceutical Catalysis • Applications in Life Sciences • Summary and Questions *Solvay partners with Strem Chemicals for sample distribution page 2 Phosphorus Specialties Strem Chemicals, Inc. Solvay partners with Strem Chemicals for sample distribution! Established in 1964 More than 55 years of experience in manufacturing and handling high quality inorganics and organometallics 5,000+ specialty chemicals available Laboratory Chemicals for R&D cGMP Products Manufactured in Kilo-lab Suites High Pressure Materials Custom Synthesis Projects Customers include: Corporate Headquarters Academic, industrial and government R&D laboratories Corporate Headquarters European Headquarters Commercial scale businesses in the pharmaceutical, Newburyport, MA USA Strasbourg, France microelectronics, chemical & petrochemical industries Phosphorus Specialties Samples available from Strem Who We Are Phosphorus Specialties Mining Solutions Polymer Additives Putting our science to work for customers to develop differentiated products and technologies Dedicated on-site technical service and applications expertise to support our customers’ needs Deep customer relationships and ongoing collaborations to solve demanding
    [Show full text]
  • Cardiovascular Monitoring with Acetylcholinesterase Inhibitors: a Clinical Protocol† Jeremy P
    Advances in Psychiatric Treatment (2007), vol. 13, 178–184 doi: 10.1192/apt.bp.106.002725 Cardiovascular monitoring with acetylcholinesterase inhibitors: a clinical protocol† Jeremy P. Rowland, John Rigby, Adam C. Harper & Rosalind Rowland Abstract There has been significant anxiety among prescribers regarding the potential for cardiac adverse effects associated with acetylcholinesterase (AChE) inhibitors in Alzheimer’s disease. There is no consensus on how to manage this cardiovascular risk, and memory clinics vary widely in their practice. Review of published evidence reveals that the incidence of cardiovascular side-effects is low, and that serious adverse events are rare. Intensive cardiovascular screening such as pre-treatment electrocardiograms or 24 h cardiac monitoring is not justified. Furthermore, there are no high-risk groups to target. This article suggests pragmatic guidelines for managing cardiovascular risk in patients receiving AChE inhibitors. The guidelines are intended to be easy to incorporate into routine clinical practice in a memory clinic. A few years ago it was estimated that almost 18 thus followed some uncertainty as to how treatment million people worldwide had dementia (Alzheimer’s should be properly managed. Society, 2004), with Alzheimer’s disease accounting Since the manufacturers’ cautions remain (see the for over half of cases (Fratiglioni, 2000). The second- relevant entries in http://emc.medicines.org.uk) and generation acetylcholinesterase (AChE) inhibitors guidance has been unforthcoming, services now vary donepezil, rivastigmine and galantamine were widely in their practice: some, for example, require introduced into clinical practice from 1997 for the electrocardiograms (ECGs) before use and during symptomatic treatment of Alzheimer’s disease, and treatment, whereas others do not.
    [Show full text]
  • Hawaii on Two Foliage Plants, Dwarf Brassaia Diazinon Plant After Spots
    in Japan and England will be given by Tosh Fu- {Brassaia arboricola) and Dwarf Ti {Cordyline chikami of O.M. Scotts and Ray McMicken of B. terminalis 'Madameandre') to determine their Hayman Co., respectively. phototoxicity to selected insecticides and acara- cides. Plants, growing in 6-inch pots, were treated Farwest Show by submerging the aerial portions of the plant in Farwest Nursery, Garden, and Supply Show water suspensions of 7 pesticides for 15seconds. will be September 8-10, 1975, at the Memorial Granular formulations of 2 pesticides were ap Coliseum in Portland, Oregon. For information plied to the soil surface. Materials, at 2X stand contact: Farwest Nursery Show, Suite GA-7, ard rates, were as follows: 222 S.W. Harrison, Protland, OR. 97201. Amount formulation per: ASHS The 72d annual meeting of ASHS (American Material and formulation 1-gallon water 6-inch pot Society for Horticultural Science) will be held in chlorobenzilate 4E 2t — Honolulu, September 8 to 13, 1975, at the dicofol (Kelthane) 35WP 2T - Sheraton-Waikiki Hotel. Meeting concurrently Pentac 50WP 2T — with ASHS will be the American Horticulture carbaryl (Sevin) 50WP 2T - Society. The University of Hawaii will host the diazinon AG500 (48% EC) 2t - meeting with Dr. Richard Bullock, general chair dimethoate (Cygon) 2E 2t — man. Dr. Henry Nakasone will serve as assistant Volck Oil Supreme 2T - general chairman, Dr. Phil Parvin as local arrange aldicarb (Temik) 10G - 1.5t ments chairman, and Dr. Richard Criley as pro disulfoton (Di-Syston) 15G - 1.5t gram chairman. Neighbor island tours will be untreated controls - conducted following the meetings.
    [Show full text]
  • Chemical Name Federal P Code CAS Registry Number Acutely
    Acutely / Extremely Hazardous Waste List Federal P CAS Registry Acutely / Extremely Chemical Name Code Number Hazardous 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro- P059 76-44-8 Acutely Hazardous 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide P050 115-29-7 Acutely Hazardous Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- P197 17702-57-7 Acutely Hazardous 1-(o-Chlorophenyl)thiourea P026 5344-82-1 Acutely Hazardous 1-(o-Chlorophenyl)thiourea 5344-82-1 Extremely Hazardous 1,1,1-Trichloro-2, -bis(p-methoxyphenyl)ethane Extremely Hazardous 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachlorooctahydro-1,3,4-metheno-1H-cyclobuta (cd) pentalene, Dechlorane Extremely Hazardous 1,1a,3,3a,4,5,5,5a,5b,6-Decachloro--octahydro-1,2,4-metheno-2H-cyclobuta (cd) pentalen-2- one, chlorecone Extremely Hazardous 1,1-Dimethylhydrazine 57-14-7 Extremely Hazardous 1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4,4a,5,6,7,8,8a-octahydro-1,4-endo-endo-5,8- dimethanonaph-thalene Extremely Hazardous 1,2,3-Propanetriol, trinitrate P081 55-63-0 Acutely Hazardous 1,2,3-Propanetriol, trinitrate 55-63-0 Extremely Hazardous 1,2,4,5,6,7,8,8-Octachloro-4,7-methano-3a,4,7,7a-tetra- hydro- indane Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]- 51-43-4 Extremely Hazardous 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, P042 51-43-4 Acutely Hazardous 1,2-Dibromo-3-chloropropane 96-12-8 Extremely Hazardous 1,2-Propylenimine P067 75-55-8 Acutely Hazardous 1,2-Propylenimine 75-55-8 Extremely Hazardous 1,3,4,5,6,7,8,8-Octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime 26419-73-8 Extremely Hazardous 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)-carbonyl]oxime.
    [Show full text]
  • Chlorobenzene
    CHLOROBENZENE What is CHLOROBENZENE? Chlorobenzene is a man-made colorless liquid that burns quickly. It has a pleasant smell like the smell of almonds. Some of it will dissolve in water. It also turns into a vapor and goes into the air. Chlorobenzene is not found in nature. Where can chlorobenzene be found and how is it used? Over the past 40 years in the United States, less cholorobenzene is being manufactured. In the past, cholorobenzene was used to make phenol and DDT. Today, it is still used to produce pesticides and chemicals used to prevent or kill unwanted pests. Chlorobenzene may be also be used to grease car parts. Chlorobenzene sent into the air is slowly broken down by other chemicals and sunlight. It can be removed from the air by rain. In water, chlorobenzene will quickly turn into a vapor, or be broken down by bacteria. When it enters soil, most of it is broken down quickly by bacteria and the rest will turn into a vapor or leach into groundwater. How can people be exposed to chlorobenzene? You could be exposed to chlorobenzene through: Breathing the chemical. People who work in places where chlorobenzene is processed or handled are at greatest risk. If you live near a waste site, you could be exposed to vapors in the air. Eating or drinking food or water that has been in contact with chlorobenzene. If you live near a waste site, you could be exposed from water contaminated by chlorobenzene. Touching soil contaminated with chlorobenzene. This happens to people who live near a waste site or a factory.
    [Show full text]
  • The List of Extremely Hazardous Substances)
    APPENDIX A (THE LIST OF EXTREMELY HAZARDOUS SUBSTANCES) THRESHOLD REPORTABLE INVENTORY RELEASE QUANTITY QUANTITY CAS NUMBER CHEMICAL NAME (POUNDS) (POUNDS) 75-86-5 ACETONE CYANOHYDRIN 500 10 1752-30-3 ACETONE THIOSEMICARBAZIDE 500/500 1,000 107-02-8 ACROLEIN 500 1 79-06-1 ACRYLAMIDE 500/500 5,000 107-13-1 ACRYLONITRILE 500 100 814-68-6 ACRYLYL CHLORIDE 100 100 111-69-3 ADIPONITRILE 500 1,000 116-06-3 ALDICARB 100/500 1 309-00-2 ALDRIN 500/500 1 107-18-6 ALLYL ALCOHOL 500 100 107-11-9 ALLYLAMINE 500 500 20859-73-8 ALUMINUM PHOSPHIDE 500 100 54-62-6 AMINOPTERIN 500/500 500 78-53-5 AMITON 500 500 3734-97-2 AMITON OXALATE 100/500 100 7664-41-7 AMMONIA 500 100 300-62-9 AMPHETAMINE 500 1,000 62-53-3 ANILINE 500 5,000 88-05-1 ANILINE,2,4,6-TRIMETHYL- 500 500 7783-70-2 ANTIMONY PENTAFLUORIDE 500 500 1397-94-0 ANTIMYCIN A 500/500 1,000 86-88-4 ANTU 500/500 100 1303-28-2 ARSENIC PENTOXIDE 100/500 1 THRESHOLD REPORTABLE INVENTORY RELEASE QUANTITY QUANTITY CAS NUMBER CHEMICAL NAME (POUNDS) (POUNDS) 1327-53-3 ARSENOUS OXIDE 100/500 1 7784-34-1 ARSENOUS TRICHLORIDE 500 1 7784-42-1 ARSINE 100 100 2642-71-9 AZINPHOS-ETHYL 100/500 100 86-50-0 AZINPHOS-METHYL 10/500 1 98-87-3 BENZAL CHLORIDE 500 5,000 98-16-8 BENZENAMINE, 3-(TRIFLUOROMETHYL)- 500 500 100-14-1 BENZENE, 1-(CHLOROMETHYL)-4-NITRO- 500/500 500 98-05-5 BENZENEARSONIC ACID 10/500 10 3615-21-2 BENZIMIDAZOLE, 4,5-DICHLORO-2-(TRI- 500/500 500 FLUOROMETHYL)- 98-07-7 BENZOTRICHLORIDE 100 10 100-44-7 BENZYL CHLORIDE 500 100 140-29-4 BENZYL CYANIDE 500 500 15271-41-7 BICYCLO[2.2.1]HEPTANE-2-CARBONITRILE,5-
    [Show full text]
  • War Gases .Pdf
    yh&% .*i From the collection of the m Prejinger h v Jjibrary San Francisco, California 2007 THE WAR GASES WAR GASES Their Identification and Decontamination BY MORRIS B. JACOBS, Ph.D. Food, Drug and Insecticide Admin. U. S. Dept. of Agr. 1927 Chemist Department of Health, City of New York, 1928. Formerly, Lt. U. S. Chemical Warfare Service Reserve INTERSCIENCE PUBLISHERS, INC. NEW YORK, N. Y.-1942 Copyright, 1942, by INTERSCIENCE PUBLISHERS, INC. 215 Fourth Avenue, New York, N. Y. Printed in U. S. A. by WAVERLY PRESS, BALTIMORE, MD. PREFACE Relatively little has been written in the United States of America on the subject of passive defense, or as we would put it, civilian defense against poison gas. One of the very first steps in defense of this nature is a system for the detection, the sampling and the identification of the chemical war- fare agents, and the decontamination of areas and materials polluted by them. It is the aim of this book to present these subjects so that the informa- tion given will be useful to the gas identification officer, the war gas chemist, the decontamination officer, and the health officer. While this book was written primarily for the aforementioned officers, Chapters I, II, III, part of IV and VII should prove of value to the air raid warden and, in general, to all persons dealing with the above mentioned phases of gas defense. It is written so that it can be used for the training of gas identifi- cation officers, as a manual by chemists and decontamination officers, and as a source of information on the analytical chemistry of the war gases.
    [Show full text]
  • Malathion Human Health and Ecological Risk Assessment Final Report
    SERA TR-052-02-02c Malathion Human Health and Ecological Risk Assessment Final Report Submitted to: Paul Mistretta, COR USDA/Forest Service, Southern Region 1720 Peachtree RD, NW Atlanta, Georgia 30309 USDA Forest Service Contract: AG-3187-C-06-0010 USDA Forest Order Number: AG-43ZP-D-06-0012 SERA Internal Task No. 52-02 Submitted by: Patrick R. Durkin Syracuse Environmental Research Associates, Inc. 5100 Highbridge St., 42C Fayetteville, New York 13066-0950 Fax: (315) 637-0445 E-Mail: [email protected] Home Page: www.sera-inc.com May 12, 2008 Table of Contents Table of Contents............................................................................................................................ ii List of Figures................................................................................................................................. v List of Tables ................................................................................................................................. vi List of Appendices ......................................................................................................................... vi List of Attachments........................................................................................................................ vi ACRONYMS, ABBREVIATIONS, AND SYMBOLS ............................................................... vii COMMON UNIT CONVERSIONS AND ABBREVIATIONS.................................................... x CONVERSION OF SCIENTIFIC NOTATION ..........................................................................
    [Show full text]